FOREST BASKETT
CIK 1277631 · last filed 2026-03-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$20.76B
Companies
69
Total Filings
226
Lifetime Open-Market Net
-$842.47M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KRRO | 10%+ Owner | 1,297,893 | $11.61 | $15.07M | $3.30M | 2 | 2026-03-12 |
| SGP | 10%+ Owner | 2,989,408 | $18.44 | $55.12M | $15.00M | 1 | 2026-02-11 |
| NeueHealth, Inc. (BHG) Delisted | Director | 488,702 | $16.35 | $7.99M | $34.99M | 5 | 2025-10-06 |
| BZFDW | 10%+ Owner | 3,674,745 | $0.03 | $96.3K | -$4.21M | 2 | 2025-03-14 |
| NeueHealth, Inc. (NEUE) Delisted | 10%+ Owner | — | $6.75 | — | $0 | 2 | 2024-10-03 |
| MBX | 10%+ Owner | 3,614,486 | $35.51 | $128.35M | $8.00M | 1 | 2024-09-17 |
| SGMT | 10%+ Owner | 3,000,275 | $6.48 | $19.44M | $0 | 1 | 2024-01-31 |
| SVRA | 10%+ Owner | 24,471,264 | $5.26 | $128.72M | $1000.0K | 1 | 2023-07-19 |
| MIRM | 10%+ Owner | 1,548 | $99.34 | $153.8K | $6.75M | 2 | 2023-06-15 |
| COUR | 10%+ Owner | 10,661,886 | $5.34 | $56.93M | $0 | 4 | 2023-02-17 |
| UTRS | 10%+ Owner | 34,437,052 | $0.00 | $3.4K | $30.00M | 1 | 2023-02-10 |
| Arcellx, Inc. (ACLX) Delisted | 10%+ Owner | 0 | $115.07 | $0 | -$51.2K | 1 | 2022-12-22 |
| Akouos, Inc. (AKUS) Delisted | 10%+ Owner | 0 | $13.29 | $0 | $10.00M | 2 | 2022-12-02 |
| IONQ.WS | 10%+ Owner | 175,378 | $46.23 | $8.11M | $0 | 1 | 2022-11-18 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | 10%+ Owner | 3,952,957 | $15.00 | $59.29M | $24.62M | 17 | 2022-10-21 |
| GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | 10%+ Owner | 0 | $0.00 | $0 | $21.03M | 4 | 2022-05-26 |
| HOOD | Director | 36,688 | $93.19 | $3.42M | -$29.6K | 5 | 2022-05-04 |
| TRVI | 10%+ Owner | 10,421,428 | $14.21 | $148.09M | $30.00M | 4 | 2022-04-13 |
| IMRA | 10%+ Owner | 3,490,673 | $17.02 | $59.41M | $54.98M | 3 | 2022-01-11 |
| Metacrine, Inc. (MTCR) Delisted | 10%+ Owner | 3,022,957 | $0.49 | $1.50M | $9.51M | 2 | 2021-12-27 |
| ARDX | 10%+ Owner | 6,207,480 | $5.69 | $35.32M | $80.59M | 10 | 2021-12-27 |
| GLUE | 10%+ Owner | 5,973,296 | $18.23 | $108.92M | $19.95M | 1 | 2021-06-30 |
| Desktop Metal, Inc. (DM) Delisted | 10%+ Owner | 806 | $4.96 | $4.0K | $0 | 1 | 2021-06-10 |
| Eargo, Inc. (EAR) Delisted | 10%+ Owner | 1,629 | $2.57 | $4.2K | $5.60M | 2 | 2021-05-26 |
| MRKR | 10%+ Owner | 10,714,285 | $1.38 | $14.79M | $10.00M | 1 | 2021-03-18 |
| Regulus Therapeutics Inc. (RGLS) Delisted | 10%+ Owner | 6,451,056 | $8.16 | $52.64M | $3.96M | 3 | 2020-12-07 |
| SPT | 10%+ Owner | 6,065,024 | $7.29 | $44.21M | -$567.90M | 3 | 2020-11-17 |
| NET | 10%+ Owner | 224,970 | $228.48 | $51.40M | -$76.53M | 6 | 2020-11-13 |
| Mersana Therapeutics, Inc. (MRSN) Delisted | 10%+ Owner | 0 | $29.08 | $0 | $14.79M | 4 | 2020-09-16 |
| Inozyme Pharma, Inc. (INZY) Delisted | 10%+ Owner | 2,000,533 | $4.00 | $8.00M | $4.00M | 1 | 2020-07-28 |
| NKTX | 10%+ Owner | 2,902,115 | $2.86 | $8.30M | $12.00M | 1 | 2020-07-16 |
| Adaptimmune Therapeutics PLC (ADAP) Delisted | 10%+ Owner | 82,978,668 | $0.06 | $4.80M | $5.00M | 1 | 2020-01-28 |
| NITE | 10%+ Owner | 0 | $37.45 | $0 | $0 | 1 | 2019-06-07 |
| TESARO, Inc. (TSRO) Delisted | 10%+ Owner | 0 | — | — | $73.04M | 7 | 2019-01-22 |
| ESTC | 10%+ Owner | 655,522 | $60.35 | $39.56M | $0 | 1 | 2018-10-10 |
| ASND | 10%+ Owner | 82,978,668 | $218.06 | $18.09B | $49.02M | 4 | 2018-09-10 |
| Surface Oncology, Inc. (SURF) Delisted | 10%+ Owner | 3,179,544 | $1.07 | $3.40M | $2.00M | 1 | 2018-04-23 |
| Tintri, Inc. (TNTR) Delisted | 10%+ Owner | — | — | — | $0 | 1 | 2018-03-02 |
| Oruka Therapeutics, Inc. (ABIO) Delisted | 10%+ Owner | 0 | $28.80 | $0 | -$731.3K | 1 | 2018-02-27 |
| Cascadian Therapeutics, Inc. (CASC) Delisted | 10%+ Owner | 10,882,574 | — | — | $0 | 1 | 2018-02-22 |
| APPN | 10%+ Owner | 27,242 | $24.01 | $654.1K | -$66.07M | 4 | 2018-02-15 |
| SYBX | 10%+ Owner | 4,228,940 | $0.69 | $2.92M | $0 | 2 | 2018-01-26 |
| Care.com Inc (CRCM) Delisted | 10%+ Owner | 433 | — | — | $0 | 2 | 2017-11-08 |
| RYTM | 10%+ Owner | 4,909,956 | $88.38 | $433.94M | $9.35M | 1 | 2017-10-10 |
| MULESOFT, INC (MULE) Delisted | 10%+ Owner | 12,679,970 | — | — | $0 | 1 | 2017-03-22 |
| Achaogen, Inc. (AKAO) Delisted | 10%+ Owner | 5,215,128 | — | — | $6.75M | 1 | 2016-12-19 |
| Tableau Software Inc (DATA) Delisted | Director | 10,833 | — | — | -$606.92M | 18 | 2016-12-06 |
| Ra Pharmaceuticals, Inc. (RARX) Delisted | 10%+ Owner | 1,858,450 | — | — | $4.39M | 1 | 2016-10-31 |
| Roka BioScience, Inc. (ROKA) Delisted | 10%+ Owner | 3,216,810 | — | — | $4.60M | 3 | 2016-09-30 |
| Epizyme, Inc. (EPZM) Delisted | 10%+ Owner | 5,854,351 | $1.47 | $8.61M | $23.85M | 4 | 2016-01-12 |
| SUPN | 10%+ Owner | 71,749 | $44.41 | $3.19M | -$3.71M | 3 | 2015-11-12 |
| Avalo Therapeutics, Inc. (CERC.U) Delisted | 10%+ Owner | 594,245 | — | — | $0 | 1 | 2015-10-20 |
| SYNLOGIC, INC. (MIRN) Delisted | 10%+ Owner | 2,114,375 | — | — | $6.00M | 1 | 2015-10-06 |
| BOX | 10%+ Owner | 2,091,457 | $25.39 | $53.10M | $0 | 1 | 2015-01-29 |
| CVENT INC (CVT) Delisted | 10%+ Owner | 10,000 | $8.52 | $85.2K | -$46.32M | 5 | 2014-11-28 |
| DERM | 10%+ Owner | 3,502,922 | $6.34 | $22.21M | $1.11M | 1 | 2014-10-08 |
| Viracta Therapeutics, Inc. (SNSS) Delisted | 10%+ Owner | 4,817,733 | $18.62 | $89.71M | -$283.8K | 4 | 2014-08-29 |
| Loxo Oncology, Inc. (LOXO) Delisted | 10%+ Owner | 1,789,420 | — | — | $3.00M | 1 | 2014-08-06 |
| AUDIENCE INC (ADNC) Delisted | Director | 0 | — | — | -$1.08M | 8 | 2013-12-04 |
| FUSION-IO, INC. (FIO) Delisted | Director | 7,053,379 | — | — | -$44.16M | 19 | 2013-11-21 |
| XOOM Corp (XOOM) Delisted | 10%+ Owner | 0 | — | — | $0 | 1 | 2013-10-31 |
| GRPN | 10%+ Owner | 54,184,956 | $17.01 | $921.69M | -$331.4K | 2 | 2013-09-17 |
| Clovis Oncology, Inc. (CLVS) Delisted | 10%+ Owner | 494 | $0.08 | $40 | $17.11M | 2 | 2013-06-05 |
| WDAY | 10%+ Owner | 2,321,212 | $130.80 | $303.61M | $0 | 2 | 2013-04-11 |
| Millennial Media Inc. (MM) Delisted | 10%+ Owner | 8,196,614 | — | — | -$21.48M | 2 | 2012-10-30 |
| HYPERION THERAPEUTICS INC (HPTX) Delisted | 10%+ Owner | 1,639,218 | — | — | $5.00M | 1 | 2012-08-02 |
| INNERWORKINGS INC (INWK) Delisted | 10%+ Owner | 15,000 | — | — | -$12.62M | 7 | 2012-03-30 |
| Echo Global Logistics, Inc. (ECHO) Delisted | 10%+ Owner | 4,000 | $48.24 | $193.0K | $0 | 1 | 2012-03-01 |
| ARYx Therapeutics, Inc. (ARYX) Delisted | 10%+ Owner | 0 | — | — | -$326.3K | 1 | 2011-03-14 |
Recent Filings · Page 2 of 23
226 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-11-02 | NeueHealth, Inc. (BHG) Delisted | Buy (P) | — | $0 | EDGAR |
| 2023-07-19 | SVRA | Buy (P) | +333,333 | $1000.0K | EDGAR |
| 2023-06-15 | MIRM | Other (J) | −1,998,452 | $0 | EDGAR |
| 2023-02-17 | COUR | Other (J) | −2,960,118 | $0 | EDGAR |
| 2023-02-10 | UTRS | Buy (P) | +146,627,562 | $30.00M | EDGAR |
| 2022-12-22 | Arcellx, Inc. (ACLX) Delisted | Mixed | −2,000,000 | -$51.2K | EDGAR |
| 2022-12-02 | Akouos, Inc. (AKUS) Delisted | U | −4,294,207 | $0 | EDGAR |
| 2022-11-18 | IONQ.WS | Other (J) | −11,682,339 | $0 | EDGAR |
| 2022-10-21 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Other (J) | −3,949,737 | $0 | EDGAR |
| 2022-10-19 | NeueHealth, Inc. (BHG) Delisted | Buy (P) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.